Last Updated: April 30, 2026

Details for New Drug Application (NDA): 018150

✉ Email this page to a colleague

« Back to Dashboard

NDA 018150 describes THALLOUS CHLORIDE TL 201, which is a drug marketed by Bracco, Curium, Ge Healthcare, Lantheus Medcl, and Trace Life, and is included in six NDAs. It is available from one supplier. Additional details are available on the THALLOUS CHLORIDE TL 201 profile page.

The generic ingredient in THALLOUS CHLORIDE TL 201 is thallous chloride tl-201. There are six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the thallous chloride tl-201 profile page.

Summary for 018150

Tradename:	THALLOUS CHLORIDE TL 201
Applicant:	Curium
Ingredient:	thallous chloride tl-201
Patents:	0

Pharmacology for NDA: 018150

Mechanism of Action	Radiopharmaceutical Activity

Suppliers and Packaging for NDA: 018150

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
THALLOUS CHLORIDE TL 201	thallous chloride tl-201	INJECTABLE;INJECTION	018150	NDA	Curium US LLC	69945-120	69945-120-56	1 VIAL in 1 CAN (69945-120-56) / 5.6 mL in 1 VIAL

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	INJECTABLE;INJECTION			Strength	1mCi/ML
Approval Date:	Approved Prior to Jan 1, 1982	TE:		RLD:	Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.